Cargando…
Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138169/ https://www.ncbi.nlm.nih.gov/pubmed/32220278 http://dx.doi.org/10.1016/S0140-6736(20)30691-7 |
| _version_ | 1783518544556720128 |
|---|---|
| author | Ritchie, Andrew I Singanayagam, Aran |
| author_facet | Ritchie, Andrew I Singanayagam, Aran |
| author_sort | Ritchie, Andrew I |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7138169 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71381692020-04-07 Immunosuppression for hyperinflammation in COVID-19: a double-edged sword? Ritchie, Andrew I Singanayagam, Aran Lancet Correspondence Elsevier Ltd. 2020 2020-03-24 /pmc/articles/PMC7138169/ /pubmed/32220278 http://dx.doi.org/10.1016/S0140-6736(20)30691-7 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Ritchie, Andrew I Singanayagam, Aran Immunosuppression for hyperinflammation in COVID-19: a double-edged sword? |
| title | Immunosuppression for hyperinflammation in COVID-19: a double-edged sword? |
| title_full | Immunosuppression for hyperinflammation in COVID-19: a double-edged sword? |
| title_fullStr | Immunosuppression for hyperinflammation in COVID-19: a double-edged sword? |
| title_full_unstemmed | Immunosuppression for hyperinflammation in COVID-19: a double-edged sword? |
| title_short | Immunosuppression for hyperinflammation in COVID-19: a double-edged sword? |
| title_sort | immunosuppression for hyperinflammation in covid-19: a double-edged sword? |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138169/ https://www.ncbi.nlm.nih.gov/pubmed/32220278 http://dx.doi.org/10.1016/S0140-6736(20)30691-7 |
| work_keys_str_mv | AT ritchieandrewi immunosuppressionforhyperinflammationincovid19adoubleedgedsword AT singanayagamaran immunosuppressionforhyperinflammationincovid19adoubleedgedsword |